Displaying drugs 15201 - 15225 of 15594 in total
FR239087
Experimental
4-Fluorophenethyl Alcohol
Experimental
Phenacetin
Phenacetin was withdrawn from the Canadian market in June 1973 due to concerns regarding nephropathy (damage to or disease of the kidney).
Withdrawn
1,3,5-trichlorobenzene
Experimental
1-(4-Amidinophenyl)-3-(4-Chlorophenyl)Urea
Experimental
N-(Chlorophenyl)-N'-hydroxyguanidine
Experimental
Cannabinor
Cannabinor, a synthetic CB2-selective agonist, is in Phase 2 clinical testing as an analgesic.
Investigational
Indisulam
Investigational
1-[4-(hydroxymethyl)phenyl]guanidine
Experimental
(3S)-1-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}pyrrolidine-3-thiol
(3S)-1-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}pyrrolidine-3-thiol is a solid. This compound belongs to the benzenesulfonamides. These are organic compounds containing a sulfonamide group that is S-linked to a benzene ring. This substance is known to target disintegrin and metalloproteinase domain-containing protein 17.
Experimental
Matched Description: … This substance is known to target disintegrin and metalloproteinase domain-containing protein 17. …
1-(4-thiophen-2-ylphenyl)methanamine
Experimental
4-(2-aminoethyl)-2-ethylphenol
Experimental
(3,4-DIHYDROXY-2-NITROPHENYL)(PHENYL)METHANONE
Experimental
Bromamphenicol
Experimental
Displaying drugs 15201 - 15225 of 15594 in total